(Circulation. 1999;100:1951-1957.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Contribution of Vasodilator Prostanoids and Nitric Oxide to Resting Flow, Metabolic Vasodilation, and Flow-Mediated Dilation in Human Coronary Circulation
Presented in part at the 70th Scientific Sessions of the American Heart Association, Orlando, Fla, November 9–12, 1997, and published in abstract form (Circulation. 1997;96[suppl I]:I-728).
From the Centre for Heart and Chest Research, Monash Medical Centre and Monash University, Melbourne, Australia.
Correspondence to Assoc Prof I.T. Meredith, Cardiovascular Centre, Monash Medical Centre, 246 Clayton Rd, Clayton, 3168, Melbourne, Australia. E-mail ian.meredith{at}med.monash.edu.au
Background—Endothelial dysfunction is associated with atherosclerosis and may contribute to ischemic syndromes. We assessed the contribution of endothelium-derived nitric oxide (NO) and vasodilator prostanoids to resting blood flow, metabolic vasodilation, and flow reserve in the human coronary circulation.
Methods and Results—Coronary hemodynamics were assessed before and after inhibition of vasodilator prostanoids and NO with intracoronary aspirin (acetylsalicylic acid [ASA]) and NG-monomethyl-L-arginine (L-NMMA), respectively. Angiographically smooth or mildly irregular vessels, with normal adenosine-induced coronary flow reserve, were studied in 25 patients undergoing clinically indicated procedures. Coronary blood velocity was measured by Doppler flow wire, and coronary blood flow (CBF) was calculated. ASA reduced resting conduit vessel diameter by 11% (P=0.003) and CBF by 27% (P=0.008) and increased coronary vascular resistance (CVR) by 24% (P<0.0001). ASA attenuated pacing-induced hyperemia by 28% (45.0±4.6 versus 32.6±3.4 mL/min, P=0.005) and increased minimum CVR by 39% (2.8±0.3 versus 3.9±0.5 mm Hg · mL-1 · min-1, P=0.007). L-NMMA reduced resting conduit vessel diameter by 9% (P=0.05) and CBF by 20% (P=0.08) and increased CVR by 19% (P=0.03). L-NMMA attenuated pacing-induced hyperemia by 20% (42.4±5.1 versus 34.1±3.4 mL/min, P=0.04) and increased minimum CVR by 33% (2.9±0.4 versus 3.8±0.5 mm Hg · mL-1 · min-1, P=0.02). ASA (7.7±2.3% versus -1.6±3.2%, P=0.06) and L-NMMA (12.1±3.9% versus 0.0±2.9%, P=0.02) abolished pacing-induced conduit vessel flow–mediated dilation.
Conclusions—Tonic release of vasodilator prostanoids and NO contributes to resting conduit and resistance vessel tone and to peak functional hyperemia and flow-mediated dilation after metabolic stimulation. This underscores the importance of normal endothelial function for metabolic vasodilation and suggests that it may be a key mechanism for preventing myocardial ischemia in coronary artery disease.
Key Words: endothelium-derived factors • prostaglandins • adenosine • blood flow • vasodilation
This article has been cited by other articles:
 |
|
 |
|
  K. Pyke, D. J. Green, C. Weisbrod, M. Best, L. Dembo, G. O'Driscoll, and M. Tschakovsky Nitric oxide is not obligatory for radial artery flow-mediated dilation following release of 5 or 10 min distal occlusion Am J Physiol Heart Circ Physiol, January 1, 2010; 298(1): H119 - H126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Casey and M. J. Joyner NOS inhibition blunts and delays the compensatory dilation in hypoperfused contracting human muscles J Appl Physiol, December 1, 2009; 107(6): 1685 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Seddon, N. Melikian, R. Dworakowski, H. Shabeeh, B. Jiang, J. Byrne, B. Casadei, P. Chowienczyk, and A. M. Shah Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo Circulation, May 26, 2009; 119(20): 2656 - 2662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Duncker and R. J. Bache Regulation of Coronary Blood Flow During Exercise Physiol Rev, July 1, 2008; 88(3): 1009 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Padilla, R. A Harris, L. D Rink, and J. P Wallace Characterization of the brachial artery shear stress following walking exercise Vascular Medicine, May 1, 2008; 13(2): 105 - 111. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans Hypertension, January 1, 2008; 51(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Duncker and D. Merkus Exercise hyperaemia in the heart: the search for the dilator mechanism J. Physiol., September 15, 2007; 583(3): 847 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Neglia, R. De Maria, S. Masi, M. Gallopin, P. Pisani, S. Pardini, A. Gavazzi, A. L'Abbate, and O. Parodi Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kaya, M. Oguz, A. R. Akar, S. Durdu, A. Aslan, S. Erturk, R. Tasoz, and U. Ozyurda The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 290 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Merkus, O. Sorop, B. Houweling, F. Boomsma, A. H. van den Meiracker, and D. J. Duncker NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2075 - H2081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Martin, W. T. Nicholson, J. H. Eisenach, N. Charkoudian, and M. J. Joyner Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia J Appl Physiol, August 1, 2006; 101(2): 492 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pistea, E. N. T. P. Bakker, J. A. E. Spaan, and E. VanBavel Flow inhibits inward remodeling in cannulated porcine small coronary arteries Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2632 - H2640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E Pyke and M. E Tschakovsky The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function J. Physiol., October 15, 2005; 568(2): 357 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Joannides and J. Bellien Flow-mediated dilatation revisited J Appl Physiol, October 1, 2005; 99(4): 1623 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Hagg, B. Wandt, G. Bergstrom, R. Volkmann, and L.-m. Gan Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1627 - H1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
REBUTTAL FROM DRS. TSCHAKOVSKY AND PYKE J Appl Physiol, September 1, 2005; 99(3): 1237 - 1238. [Full Text] [PDF]
|
|
|
|
|
|
J. Bellien, R. Joannides, M. Iacob, P. Arnaud, and C. Thuillez Calcium-Activated Potassium Channels and NO Regulate Human Peripheral Conduit Artery Mechanics Hypertension, July 1, 2005; 46(1): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Clifford and Y. Hellsten Vasodilatory mechanisms in contracting skeletal muscle J Appl Physiol, July 1, 2004; 97(1): 393 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Tune, M. W. Gorman, and E. O. Feigl Matching coronary blood flow to myocardial oxygen consumption J Appl Physiol, July 1, 2004; 97(1): 404 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. O. Farouque, S. G. Worthley, and I. T. Meredith Effect of ATP-Sensitive Potassium Channel Inhibition on Coronary Metabolic Vasodilation in Humans Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 905 - 910. [Abstract] [Full Text]
|
|
|
|
|
|
D. Merkus, B. Houweling, A. Zarbanoui, and D. J. Duncker Interaction between prostanoids and nitric oxide in regulation of systemic, pulmonary, and coronary vascular tone in exercising swine Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1114 - H1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Title, K. Giddens, M. M. McInerney, M. J. McQueen, and B. A. Nassar Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1747 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Yki-Jarvinen, R Bergholm, and M Leirisalo-Repo Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis Ann Rheum Dis, July 1, 2003; 62(7): 630 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Merkus, D. B. Haitsma, T.-Y. Fung, Y. J. Assen, P. D. Verdouw, and D. J. Duncker Coronary blood flow regulation in exercising swine involves parallel rather than redundant vasodilator pathways Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H424 - H433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. O. Farouque and I. T. Meredith Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2405 - H2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Blumenthal, D. M. Becker, L. R. Yanek, T. R. Aversano, T. F. Moy, B. G. Kral, and L. C. Becker Detecting Occult Coronary Disease in a High-Risk Asymptomatic Population Circulation, February 11, 2003; 107(5): 702 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Boushel, H. Langberg, C. Gemmer, J. Olesen, R. Crameri, C. Scheede, M. Sander, and M. Kjaer Combined inhibition of nitric oxide and prostaglandins reduces human skeletal muscle blood flow during exercise J. Physiol., September 1, 2002; 543(2): 691 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. O. Farouque, S. G. Worthley, I. T. Meredith, R. A. P. Skyrme-Jones, and M. J. Zhang Effect of ATP-Sensitive Potassium Channel Inhibition on Resting Coronary Vascular Responses in Humans Circ. Res., February 8, 2002; 90(2): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF]
|
|
|
|
|
|
S. Verma, S. R. Raj, L. Shewchuk, K. J. Mather, and T. J. Anderson Cyclooxygenase-2 Blockade Does Not Impair Endothelial Vasodilator Function in Healthy Volunteers: Randomized Evaluation of Rofecoxib Versus Naproxen on Endothelium-Dependent Vasodilatation Circulation, December 11, 2001; 104(24): 2879 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia Circulation, November 6, 2001; 104(19): 2305 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Naber, D. Baumgart, C. Altmann, W. Siffert, R. Erbel, and G. Heusch eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H1908 - H1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. A. WIEREMA, A. J. H. M. HOUBEN, A. A. KROON, D. KOSTER, K. V. D. ZANDER, J. M. A. V. ENGELSHOVEN, and P. W. D. LEEUW Nitric Oxide Dependence of Renal Blood Flow in Patients with Renal Artery Stenosis J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1836 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Duffy, E. S. Biegelsen, M. Holbrook, J. D. Russell, N. Gokce, J. F. Keaney Jr, and J. A. Vita Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease Circulation, June 12, 2001; 103(23): 2799 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lamping Interactions Between NO and cAMP in the Regulation of Vascular Tone Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 729 - 730. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Mullen, R. K. Kharbanda, J. Cross, A. E. Donald, M. Taylor, P. Vallance, J. E. Deanfield, and R. J. MacAllister Heterogenous Nature of Flow-Mediated Dilatation in Human Conduit Arteries In Vivo : Relevance to Endothelial Dysfunction in Hypercholesterolemia Circ. Res., February 2, 2001; 88(2): 145 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Gauthier and N. J. Rusch Rat Coronary Endothelial Cell Membrane Potential Responses During Hypertension Hypertension, January 1, 2001; 37(1): 66 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Lamping, D. W. Nuno, E. G. Shesely, N. Maeda, and F. M. Faraci Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1906 - H1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. O. Farouque, S. G. Worthley, I. T. Meredith, R. A. P. Skyrme-Jones, and M. J. Zhang Effect of ATP-Sensitive Potassium Channel Inhibition on Resting Coronary Vascular Responses in Humans Circ. Res., February 8, 2002; 90(2): 231 - 236. [Abstract] [Full Text] [PDF]
|
|